Vanguard Group Inc Vor Biopharma Inc. Transaction History

Vanguard Group Inc

$5.12 Trillion
Q2 2024

A detailed history of Vanguard Group Inc transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,954,285 shares of VOR stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,954,285

Previous 1,812,899 7.8%

Holding current value

$1.56 Million

Previous $4.3 Million 54.52%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.0 - $2.2 $141,386 - $311,049	141,386 Added 7.8%	1,954,285 $1.95 Million
Q1 2024 May 10, 2024	BUY	$1.8 - $2.85 $124,984 - $197,892	69,436 Added 3.98%	1,812,899 $4.3 Million
Q4 2023 Feb 14, 2024	BUY	$1.66 - $2.63 $44,848 - $71,054	27,017 Added 1.57%	1,743,463 $3.92 Million
Q3 2023 Nov 14, 2023	BUY	$2.1 - $3.35 $8,326 - $13,282	3,965 Added 0.23%	1,716,446 $3.64 Million
Q2 2023 Aug 14, 2023	BUY	$3.09 - $5.33 $411,535 - $709,865	133,183 Added 8.43%	1,712,481 $5.29 Million
Q1 2023 May 15, 2023	BUY	$4.68 - $6.96 $1.82 Million - $2.7 Million	387,968 Added 32.57%	1,579,298 $8.5 Million
Q4 2022 Feb 10, 2023	BUY	$3.77 - $7.43 $2.01 Million - $3.97 Million	534,188 Added 81.29%	1,191,330 $7.92 Million
Q2 2022 Aug 12, 2022	SELL	$3.89 - $6.44 $12,856 - $21,284	-3,305 Reduced 0.5%	657,142 $3.27 Million
Q1 2022 May 13, 2022	SELL	$6.04 - $12.23 $1.76 Million - $3.57 Million	-291,679 Reduced 30.63%	660,447 $3.99 Million
Q4 2021 Feb 14, 2022	SELL	$11.32 - $18.02 $3.95 Million - $6.29 Million	-348,930 Reduced 26.82%	952,126 $11.1 Million
Q3 2021 Nov 12, 2021	BUY	$12.24 - $20.38 $5.6 Million - $9.33 Million	457,673 Added 54.27%	1,301,056 $20.4 Million
Q2 2021 Aug 13, 2021	BUY	$18.65 - $38.78 $15.7 Million - $32.7 Million	843,383 New	843,383 $15.7 Million

Others Institutions Holding VOR

# of Institutions

Shares Held

48M

Call Options Held

1.5K

Put Options Held

View Full List

About Vor Biopharma Inc.

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $30.4M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

More about VOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Vor Biopharma Inc. Transaction History